Global Indemnity Group, LLC - Class A Common Stock (GBLI)
30.08
-0.20 (-0.66%)
NYSE · Last Trade: Jun 1st, 12:01 PM EDT

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via Benzinga · March 13, 2024

Via Benzinga · December 18, 2023

GBLI stock results show that Global Indemnity Group beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024